详解“十四五”市场监管改革：规范监管与促进发展并重

Group 1: Market Regulation Achievements - The State Administration for Market Regulation (SAMR) highlighted significant achievements in high-quality market regulation during the 14th Five-Year Plan period, focusing on business environment, market operation, and safety supervision [2][5] - Key areas of focus include reforms in the registered capital system, prevention of excessive penalties for minor infractions, addressing platform economy issues, food safety, and innovation drug approval reforms [2][5] Group 2: Registered Capital Reform - The revised Company Law in 2023 stipulates that the maximum contribution period for limited liability company shareholders is five years, effective from July 1, 2024 [3][5] - The reform aims to curb market irregularities such as inflated registered capital and excessively long contribution periods, enhancing the credibility of registered capital [5][6] Group 3: Prevention of Excessive Penalties - The SAMR is implementing a "double random, one public" regulatory approach to minimize disruptions to normal business operations and enhance administrative enforcement standards [6][7] - A typical case highlighted the issue of disproportionate penalties, prompting the SAMR to withdraw an excessive fine against a local restaurant [6][7] Group 4: Platform Economy Regulation - The SAMR is addressing issues in the platform economy, including algorithm abuse and unfair competition, through ongoing regulatory actions [8][9] - Over the past five years, the SAMR has taken significant actions, including deleting 4.541 million pieces of illegal product information and investigating 105,000 internet-related cases [8][9] Group 5: Food Safety Oversight - Food safety remains a critical focus, with the SAMR enhancing compliance guidance for platform enterprises and increasing special inspections to address issues like "ghost deliveries" and false claims [12][13] - The SAMR has introduced new regulations to clarify food safety responsibilities among various stakeholders in the online food sales ecosystem [12][13] Group 6: Innovation Drug Approval - The pharmaceutical industry in China has seen rapid development, with 204 innovative drugs and 265 innovative medical devices approved since the beginning of the 14th Five-Year Plan [14][15] - The SAMR is streamlining the drug approval process, aiming to complete reviews of key innovative drugs within 30 working days and significantly reducing the time for supplementary application reviews [14][15]